De Benedetti, F. Et Al. 2018. Long-Term Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant FMF (crFMF), Hids/Mkd and TRAPS: Results from the Pivotal Phase 3 Cluster Trial. ARTHRITIS & RHEUMATOLOGY , vol.70 .

De Benedetti, F., Frenkel, J., Simon, A., Anton, J., Lachmann, H. J., Gattorno, M., ... ÖZEN, S.(2018). Long-Term Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant FMF (crFMF), Hids/Mkd and TRAPS: Results from the Pivotal Phase 3 Cluster Trial. ARTHRITIS & RHEUMATOLOGY , vol.70.

De Benedetti, Fabrizio Et Al. "Long-Term Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant FMF (crFMF), Hids/Mkd and TRAPS: Results from the Pivotal Phase 3 Cluster Trial," ARTHRITIS & RHEUMATOLOGY , vol.70, 2018

De Benedetti, Fabrizio D. Et Al. "Long-Term Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant FMF (crFMF), Hids/Mkd and TRAPS: Results from the Pivotal Phase 3 Cluster Trial." ARTHRITIS & RHEUMATOLOGY , vol.70, 2018

De Benedetti, F. Et Al. (2018) . "Long-Term Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant FMF (crFMF), Hids/Mkd and TRAPS: Results from the Pivotal Phase 3 Cluster Trial." ARTHRITIS & RHEUMATOLOGY , vol.70.

@article{article, author={Fabrizio De Benedetti Et Al. }, title={Long-Term Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant FMF (crFMF), Hids/Mkd and TRAPS: Results from the Pivotal Phase 3 Cluster Trial}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2018}